Regul Toxicol Pharmacol

• 

  Publication Venue For

  • Interplay of gender, age and drug properties on reporting frequency of drug-induced liver injury..  94:101-107. 2018
  • Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort..  77:257-262. 2016
  • Children's liver chemistries vary with age and gender and require customized pediatric reference ranges..  73:349-355. 2015
  • Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™..  72:481-490. 2015
  • Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database..  70:519-526. 2014
  • A pre-marketing ALT signal predicts post-marketing liver safety..  63:433-439. 2012
  • Sucralose revisited: rebuttal of two papers about Splenda safety..  63:505-508. 2012
  • The evaluation of drug rechallenge: the casopitant Phase III program..  58:539-543. 2010